Psilocybin for Methamphetamine Addiction

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 4, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions

Methamphetamine Use Disorder

Interventions

DRUG

Psilocybin 25 mg

25 mg administered orally (capsules)

Trial Locations (1)

RECRUITING

LSU Health Shreveport, Shreveport

All Listed Sponsors

lead

Kevin Murnane

OTHER

NCT06899594 - Psilocybin for Methamphetamine Addiction | Biotech Hunter | Biotech Hunter